Company Filing History:
1 out of 894 
1 out of 31 
Years Active: 1998
Title: The Innovative Contributions of Amos Shapiro
Introduction
Amos Shapiro is a notable inventor based in Mevaseret Ziyon, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of superficial bladder carcinoma. His innovative approach has led to the development of a method that aids in predicting patient responses to treatment.
Latest Patents
Amos Shapiro holds a patent for a method titled "Method for predicting the response to treatment with BCG of superficial bladder carcinoma." This invention relates to a method and kit designed to predict how a patient suffering from superficial bladder carcinoma will respond to treatment with bacillus Calmette-Guerin (BCG). The method involves calculating the inducibility of the Interleukin-2 (IL-2) gene in a sample of peripheral blood mononuclear (PBM) cells from the patient. The process includes culturing PBM cells in the presence and absence of an inducing agent, followed by a quantitative determination of IL-2 gene expression. The resulting ratio provides insight into the likelihood of remission, relapse, or persistence of the cancer.
Career Highlights
Throughout his career, Amos Shapiro has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hadasit Medical Research Services and Development Company. His work has been instrumental in advancing medical research and treatment methodologies.
Collaborations
Amos Shapiro has collaborated with various professionals in the field, including his coworker Raymond Kaempfer. Their joint efforts have contributed to the development of innovative solutions in medical research.
Conclusion
Amos Shapiro's contributions to the field of medical research, particularly in predicting treatment responses for bladder carcinoma, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to influence the medical community and offers hope for better treatment strategies.